Childrens Hospital Medical Center

Childrens Hospital Medical Center, doing business as Children's Home Healthcare, is a tax-exempt nonprofit pediatric hospital and research center headquartered in Cincinnati, Ohio, operating as a prime recipient of federal grants and contract awardee across the National Institutes of Health and Centers for Disease Control and Prevention. The organization competes in full-and-open federal markets without set-aside designations and serves as a leading recipient of federal grant funding for pediatric clinical research, vaccine safety assessment, and translational biomedical research rather than as a federal contractor delivering goods or services.

Over the past five years, Cincinnati Children's has received 1,755 prime awards totaling $1.31 billion in combined potential value across 95 distinct federal agencies, with $4.42 billion in actual obligations reflecting the multi-year nature of research grants. The top five customer agencies—National Institute of Allergy and Infectious Diseases (217 awards, $1.11 billion), Centers for Disease Control and Prevention (23 awards, $102.2 million), National Institute of Diabetes and Digestive and Kidney Diseases (151 awards, $22.8 million), National Institute of Child Health and Human Development (119 awards, $13.8 million), and National Heart, Lung, and Blood Institute (269 awards, $8.3 million)—account for 96 percent of combined potential value. The vendor's award footprint concentrates in research and development in life sciences (37 awards) and health care services including reference laboratory testing and clinical research support.

Cincinnati Children's capability portfolio centers on pediatric clinical research, vaccine safety assessment, and translational biomedical research spanning infectious disease, immunology, genetic and developmental disorders, and pediatric therapeutic development. Representative recent work includes a $5.541 million NIAID project grant investigating vertically transferred maternal antibodies protecting newborns from E. coli infection; a $12.904 million NHLBI Cooperative Agreement to serve as data coordinating center for the Bench to Bassinet Congenital Heart Disease Advancing New Understanding in Genomics (B2B CHANGE) cohort, enrolling over 14,000 congenital heart disease patients and 18,000 family members; a $3.24 million trans-NIH Cooperative Agreement to establish the Cincinnati Advanced NAM Development and Operational Research Center (CANDOR) developing patient-specific in vitro organoid and in silico models for inflammatory bowel disease, steatotic liver disease, and pancreatitis; and a $1.614 million NINDS project grant investigating epileptogenesis mechanisms in mtoropathies using AAV-mediated gene therapy approaches. On the contract side, Cincinnati Children's holds a clinical immunization safety assessment IDIQ with the CDC under the 2023 CISA Base program, with a ceiling of $86.008 million through September 25, 2028, having generated three delivery orders for vaccine safety monitoring and the CISA RSV Infants Study lead site work.

Federal grant activity shows sustained volume, with 143 awards in 2023, 229 in 2024, 228 in 2025, and 150 through recent reporting, indicating a peak in 2024–2025. The 213 awards reaching completion in the next twenty-four months carry combined potential value of $1.9 million and represent recompete exposure primarily in continuation awards from NIH institutes. Service Contract Inventory data covering federal service contracts above $150,000 shows $10.9 million in SCI-reportable invoiced revenue across FY2022–FY2024 (FY2025 shows zero, likely due to reporting lag), with 15.9–17.1 FTEs delivered annually. Median government-paid hourly rates on federal services contracts run approximately $117.63/hr, with senior labor pricing spanning $90.80/hr to $166.55/hr across the 10th and 90th percentiles, reflecting clinical research leadership and scientific staff cost structures. Sub-engagement on SCI-reportable contracts is minimal (1% of total contractor hours), indicating Cincinnati Children's builds delivery primarily through its own workforce rather than subcontractor reliance.

The vendor operates as prime on 77 percent of awards and subcontractor on 23 percent, with sub-award work concentrated under large prime research initiatives at Johns Hopkins University, The Children's Hospital of Philadelphia, Vanderbilt University Medical Center, Emory University, and UCLA. Representative sub roles include serving as site principal investigator or coordinating center for multi-site clinical trials, conducting tissue analysis and mechanistic studies under translational research programs, and contributing specialized expertise in pediatric hematology, immunology, respiratory physiology, and patient enrollment and management. The organization holds no prominent position on government-wide acquisition vehicles or agency-wide IDIQs beyond the CDC CISA contract; its federal footprint derives from direct awards from NIH institutes, CDC, NSF, and Defense Health Agency based on institutional research capacity, investigator expertise, and clinical infrastructure serving pediatric populations. Federal grant work spans basic discovery research, translational studies using iPSC-derived organoids and mouse models, clinical trial design and execution, and data coordination for multi-site consortia, with performance located at Cincinnati, Ohio facilities.